Role of Ultrasound Surveillance of Transjugular Intrahepatic Portosystemic Shunts in the Covered Stent Era

2006 ◽  
Vol 17 (8) ◽  
pp. 1297-1305 ◽  
Author(s):  
Caitlin E. Carr ◽  
Catherine M. Tuite ◽  
Michael C. Soulen ◽  
Richard D. Shlansky-Goldberg ◽  
Timothy W.I. Clark ◽  
...  
2020 ◽  
Vol 13 ◽  
pp. 175628482096128 ◽  
Author(s):  
Judit Vidal-González ◽  
Sergi Quiroga ◽  
Macarena Simón-Talero ◽  
Joan Genescà

Portal hypertension is the main consequence of liver cirrhosis, leading to severe complications such as variceal hemorrhage, ascites or hepatic encephalopathy. As an attempt to decompress the portal venous system, portal flow is derived into the systemic venous system through spontaneous portosystemic shunts (SPSSs), bypassing the liver. In this review, we aim to provide an overview of the published reports in relation to the prevalence and physiopathology behind the appearance of SPSS in liver cirrhosis, as well as the complications derived from its formation and its management. The role of SPSS embolization is specifically discussed, as SPSSs have been assessed as a therapeutic target, mainly for patients with recurrent/persistent hepatic encephalopathy and preserved liver function. Furthermore, different aspects of the role of SPSS in liver transplantation, as well as in candidates for transjugular intrahepatic portosystemic shunt are reviewed. In these settings, SPSS occlusion has been proposed to minimize possible deleterious effects, but results are so far inconclusive.


Radiology ◽  
2005 ◽  
Vol 236 (2) ◽  
pp. 725-729 ◽  
Author(s):  
Charles T. Lau ◽  
Mark Scott ◽  
S. William Stavropoulos ◽  
Michael C. Soulen ◽  
Jeffery A. Solomon ◽  
...  

1994 ◽  
Vol 5 (2) ◽  
pp. 377-378 ◽  
Author(s):  
Myron M. Wojtowycz ◽  
Robert H. Tambeaux ◽  
Michael R. Schuster
Keyword(s):  

1992 ◽  
Vol 10 (1) ◽  
pp. 74-83 ◽  
Author(s):  
Antonino Cavallari ◽  
Emilio De Raffele ◽  
Roberto Bellusci ◽  
Romano Bragaglia ◽  
Bruno Nardo ◽  
...  

HPB Surgery ◽  
1992 ◽  
Vol 5 (4) ◽  
pp. 287-290
Author(s):  
Roy L. Gordon
Keyword(s):  

1978 ◽  
Vol 89 (2) ◽  
pp. 284-295 ◽  
Author(s):  
J. L. Schlienger ◽  
M. Hasselmann ◽  
M. Imler

ABSTRACT Serum concentrations of thyroid hormones (T3, T4) and the TSH response to TRH administered iv were measured by radioimmunoassay in 21 patients with advanced cirrhosis and compared to 20 control patients without liver disease (group A). While the mean T4 values (8.6±0.3 μg/100 ml) were similar for the two groups, the mean T3 values were significantly lower in patients with liver disease (123 ± 12 vs. 156 ± 10 ng/100 ml). The mean baseline TSH levels and the magnitude of the peak were normal but very scattered in these patients. The TSH response to TRH appeared independant of nutritional status, T4 and T3, anaemia, hypoalbuminaemia, transaminasaemia and bilirubinaemia. The TSH release after TRH injection seemed however to be markedly elevated in cirrhotic patients with hyperammonaemia. Therefore, patients with liver disease were separated into two groups according to the absence (group B; n = 11) or the presence (group C; n = 10) of hyperammonaemia. Mean T4 values and the free thyroxine index were lower in group C (7.2 ± 0.6 vs. 9 ± 0.6 μg/100 ml and 1.87 ± 0.16 vs. 2.49 ± 0.15) but mean T3 and basal TSH values did not differ in group B and C. The TSH response was slightly dispersed in B and lower than that observed in A or in C (P < 0.01). A hyperresponsiveness in 4 patients and a hyperresponsiveness in 2 other patients was noted in group C without any correlation with the basal TSH value or T3 or T4 Since hyperammonaemia has been considered as a biological parameter of hepatic encephalopathy, it is suggested that the THS release which is neuraminergic controlled may be altered by this situation resulting in a cerebral aminergic mediators depletion.


Sign in / Sign up

Export Citation Format

Share Document